Home › Funds › TPG GP A, LLC › BCAX

TPG GP A, LLC position in BCAX

BICARA THERAPEUTICS INC · Health Care

TPG GP A, LLC reported holding 3,010,425 shares of BCAX (BICARA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$89.4M, representing 1.84% of its reported portfolio and ranking #10 among its reported holdings. TPG GP A, LLC has disclosed BCAX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)3.01M sh
Reported value held$89.38M
Portfolio Weight1.84%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TPG GP A, LLC's BCAX position evolved

TPG GP A, LLC first disclosed a stake in BCAX in Q3 2024 at 3,010,425 shares (US$76.7M). The position peaked in Q2 2026 at 3,010,425 shares, worth US$89.4M. Across 8 filings, TPG GP A, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,010,425 shares valued at US$89.4M.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 3.01M $76.68M New
Q4 2024 3.01M $52.44M Hold
Q1 2025 3.01M $39.23M Hold
Q2 2025 3.01M $27.97M Hold
Q3 2025 3.01M $47.53M Hold
Q4 2025 3.01M $50.67M Hold
Q1 2026 3.01M $59.88M Hold
Q2 2026 3.01M $89.38M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCAX and 13F data

BCAX (BICARA THERAPEUTICS INC) is a Health Care company. 58 other funds we track also report a position in BCAX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$215.4M), Siren, L.L.C. (US$166.4M), Vestal Point Capital, LP (US$155.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCAX

All BCAX fund holders →

FAQ

How long has TPG GP A, LLC held BCAX?

TPG GP A, LLC has disclosed BCAX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is TPG GP A, LLC's current position in BCAX?

As of Q2 2026, TPG GP A, LLC holds 3.01M shares of BCAX (BICARA THERAPEUTICS INC), valued at $89.38M, representing 1.84% of its reported portfolio and ranking #10.

Has TPG GP A, LLC been buying or selling BCAX?

In the latest 13F filing (Q2 2026), TPG GP A, LLC held unchanged its position in BCAX. The position peaked in Q2 2026 at 3.01M shares.

Which other funds hold BCAX?

Other major institutional holders of BCAX include RA CAPITAL MANAGEMENT, L.P., Siren, L.L.C., Vestal Point Capital, LP, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.